FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely to pediatric neurology, and can be used to predict convulsions in term infants in the late neonatal period. TNF-alpha and MMP-3 are measured in blood serum in term infants in the early neonatal period. If the TNF-alpha concentration is 69.3 pg/ml and higher, and MMP-3 is 101.4 pg/ml and higher, neonatal seizures in the late neonatal period are predicted.
EFFECT: invention enables accurate and reliable prediction of neonatal convulsions in newborns with perinatal hypoxic-ischemic CNS involvement.
1 cl, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING CENTRAL NERVOUS SYSTEM DISORDERS IN NEWBORNS BELONGING TO PERINATAL RISK GROUP | 2004 |
|
RU2276365C1 |
| METHOD FOR DIAGNOSING NEUROIMMUNE DISORDERS IN YOUNG CHILDREN WITH EPILEPSY | 2021 |
|
RU2767271C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING MORPHOLOGICAL CHANGES OF BRAIN IN THE FULL-TERM NEWBORNS WITH PERINATAL HYPOXIC-ISCHEMIC INVOLVEMENT OF THE NERVOUS SYSTEM | 2020 |
|
RU2737490C1 |
| METHOD FOR PREDICTION OF CLINICAL COURSE OF HYPOXIC-ISCHEMIC CENTRAL NERVOUS SYSTEM INJURY IN INFANTS | 2012 |
|
RU2487360C1 |
| METHOD FOR PREDICTION OF INFANTILE CEREBRAL PARALYSIS IN INFANTS | 2013 |
|
RU2540514C1 |
| METHOD FOR PREDICTING EARLY NEONATAL CONVULSIVE DISORDER IN CHILDREN SUFFERING PERINATAL INJURIES OF CENTRAL NERVOUS SYSTEM | 2014 |
|
RU2548758C1 |
| METHOD FOR PREDICTION OF RISK OF NEUROLOGICAL DEFICIENCY DEVELOPMENT IN PREMATURE NEWBORNS WITH HYPOXIC BRAIN DAMAGE | 2016 |
|
RU2635461C1 |
| METHOD FOR PREDICTING THE UNFAVORABLE COURSE OF EPILEPSY IN CHILDREN IN THE FIRST YEAR OF LIFE | 2022 |
|
RU2787512C1 |
| METHOD OF PREDICTING RISK OF DEVELOPMENT OF NEUROLOGICAL DEFICIENCY IN FULL-TERM NEW-BORN BABIES WITH HYPOXIC-ISCHEMIC BRAIN INJURY | 2014 |
|
RU2565095C1 |
| METHOD FOR PREDICTION OF RISK OF PERINATAL CENTRAL NERVOUS SYSTEM DISORDER IN NEONATAL PERIOD IN FULL-TERM INFANTS SUFFERED BIRTH ASPHYXIA | 2011 |
|
RU2465595C1 |
